News & Events
-
Watch HOPE Summit 2026 Videos
HOPE Summit 2026 was filled with old friends reuniting, new friends being made, and of course, plenty of inspirational and informative sessions designed to help people live well with lung cancer.
For...
-
Clinical Trial Access Isn’t Expanding. It’s Concentrating.
Clinical trials show us whether a new treatment is safe and effective. They are also an important way for patients to access cutting-edge care. For trials to truly serve the lung... -
Podcast: Lung Cancer Diagnosis—What Happens Next
What happens after a lung cancer diagnosis? In this first episode of LUNGevity’s Lung Cancer Voices of Hope podcast, lung cancer survivor Lisa Bistline shares her experience, from... -
Podcast: Why Community Matters in Lung Cancer Care
Why does finding community matter in lung cancer care? In this episode, lung cancer survivor and advocate Jill Feldman shares her experience, from losing multiple family members to... -
Scalp Care, Shaving, and Head Coverings: Comfort Through Hair Loss
This video is a recording from a LUNGevity virtual meetup. Each month, we host multiple virtual meetups for those impacted by lung cancer to meet and connect with others who... -
Meet The “Mini-Organs” of Lung Cancer Research
Though many of us would like to deny it, our neighbors affect us. Their loud music disturbs our sleep. The scent of their dinner wafts through an open window. The sight of their... -
Three Moments That Defined the 2026 Targeted Therapies of Lung Cancer Conference
The 2026 Targeted Therapies of Lung Cancer Meeting brought together leading clinicians, researchers, and patient advocates to discuss the latest advances shaping the future of lung... -
Progress in Cancer Care: What the Numbers Tell Us About Lung Cancer
Every January, the American Cancer Society releases a Cancer Facts & Figures report. It provides a clear view of where we stand in addressing cancer. The 2026 report brings both... -
KRAS Virtual Meetup
Join us the 3rd Wednesday of every month to c onnect with others who share common experiences and build your community. After registering, you will receive a confirmation email... -
Why Immunotherapy Isn’t Perfect & How Scientists Are Working to Fix It
The human immune system is an intricate web of checks and balances that usually excels at detecting and destroying foreign invaders, such as bacteria and viruses, while protecting...
Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer
Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer
Divarasib improves survival in previously treated KRAS G12C mutated advanced NSCLC
ESMO Congress 2026: Next-generation KRAS inhibitor outperforms rivals in lung cancer
Divarasib Beats Approved KRAS Inhibitors in Lung Cancer
Ben Solomon: New Standard of Care for KRAS G12C Mutation Positive NSCLC
New targeted therapy improved survival for patients with KRAS-mutated lung cancer
Calderasib Regimen Shows Meaningful Responses in Frontline KRAS G12C+ NSCLC
Ahmed Alanazi: Phase III KRASCENDO 1 Reports Superior Efficacy of Divarasib in KRAS G12C–Mutated NSCLC
Ahmed Alanazi: Phase III KRASCENDO 1 Reports Superior Efficacy of Divarasib in KRAS G12C–Mutated NSCLC
Roche’s Next-Gen Divarasib Bests Approved KRAS G12C Inhibitors in Head-to-Head NSCLC Trial
Roche’s Next-Gen Divarasib Bests Approved KRAS G12C Inhibitors in Head-to-Head NSCLC Trial
UPMC Hillman study finds CASTOR1 loss drives KRAS inhibitor resistance in lung cancer models
UPMC Hillman study finds CASTOR1 loss drives KRAS inhibitor resistance in lung cancer models